BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McMahon LP, MacGinley R; KHA-CARI. KHA-CARI guideline: biochemical and haematological targets: haemoglobin concentrations in patients using erythropoietin-stimulating agents. Nephrology (Carlton) 2012;17:17-9. [PMID: 22044720 DOI: 10.1111/j.1440-1797.2011.01535.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Morris M, Snedeker M, Reed G, Butcher B, Bradley J. Do iron guidelines translate into good clinical practice for patients on haemodialysis? J Ren Care 2014;40:49-54. [PMID: 24588980 DOI: 10.1111/j.1755-6686.2013.12036.x] [Reference Citation Analysis]
2 Ethier I, Cho Y, Hawley C, Pascoe EM, Roberts MA, Semple D, Nadeau-Fredette AC, Sypek MP, Viecelli A, Campbell S, van Eps C, Isbel NM, Johnson DW. Effect of patient- and center-level characteristics on uptake of home dialysis in Australia and New Zealand: a multicenter registry analysis. Nephrol Dial Transplant 2020;35:1938-49. [PMID: 32031636 DOI: 10.1093/ndt/gfaa002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Roger SD, Jassal SV, Woodward MC, Soroka S, Mcmahon LP. A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE. Int Urol Nephrol 2014;46:469-75. [DOI: 10.1007/s11255-013-0512-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
4 Thomas A, Silver SA, Perl J, Freeman M, Slater JJ, Nash DM, Vinegar M, McArthur E, Garg AX, Harel Z, Chanchlani R, Zappitelli M, Iliescu E, Kitchlu A, Blum D, Beaubien-Souligny W, Wald R. The Frequency of Routine Blood Sampling and Patient Outcomes Among Maintenance Hemodialysis Recipients. Am J Kidney Dis 2020;75:471-9. [PMID: 31732233 DOI: 10.1053/j.ajkd.2019.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Roger SD, Tio M, Park HC, Choong HL, Goh B, Cushway TR, Stevens V, Macdougall IC. Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis. Nephrology (Carlton) 2017;22:969-76. [PMID: 27699922 DOI: 10.1111/nep.12940] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
6 Majoni SW, Ellis JA, Hall H, Abeyaratne A, Lawton PD. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia. Hemodial Int 2014;18:740-50. [PMID: 24766376 DOI: 10.1111/hdi.12173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
7 Oliver V, Stephenson M. Prevention, assessment and management of post-dialysis fatigue in patients attending in-center hemodialysis: a best practice implementation project. JBI Database System Rev Implement Rep 2016;14:278-88. [PMID: 27941521 DOI: 10.11124/JBISRIR-2016-003189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
8 Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, Port FK, Pisoni RL, Robinson BM. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol 2015;10:98-109. [PMID: 25516917 DOI: 10.2215/CJN.12941213] [Cited by in Crossref: 156] [Cited by in F6Publishing: 72] [Article Influence: 19.5] [Reference Citation Analysis]
9 Nadeau-Fredette AC, Johnson DW, Hawley CM, Pascoe EM, Cho Y, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP. Center-Specific Factors Associated with Peritonitis Risk-A Multi-Center Registry Analysis. Perit Dial Int 2016;36:509-18. [PMID: 26764341 DOI: 10.3747/pdi.2015.00146] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
10 Pilmore H, Dogra G, Roberts M, Lambers Heerspink HJ, Ninomiya T, Huxley R, Perkovic V. Cardiovascular disease in patients with chronic kidney disease. Nephrology (Carlton) 2014;19:3-10. [PMID: 23927055 DOI: 10.1111/nep.12148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
11 Szeto CC, Lo WK, Li PK. Clinical practice guidelines for the provision of renal service in Hong Kong: Peritoneal Dialysis. Nephrology 2019;24:27-40. [DOI: 10.1111/nep.13505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Macginley RJ, Walker RG. International treatment guidelines for anaemia in chronic kidney disease - what has changed? Med J Aust 2013;199:84-5. [PMID: 23879487 DOI: 10.5694/mja13.10538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Trowbridge L, Kruger A, Arnold A, Butcher B, Bradley J. Are haemoglobin levels adequate in patients with chronic kidney disease (CKD) stage 2-4? J Ren Care 2013;39:194-9. [PMID: 23782818 DOI: 10.1111/j.1755-6686.2013.12016.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Johnson DW, Cleland B, Eris J, Rafferty T, Sud K, Chow JS. Administration of erythropoiesis-stimulating agents in patients undergoing haemodialysis: A time and motion study. J Ren Care 2017;43:219-25. [PMID: 28901048 DOI: 10.1111/jorc.12213] [Reference Citation Analysis]
15 Ethier I, Boudville N, McDonald S, Brown F, Kerr PG, Walker R, Holt SG, Badve SV, Cho Y, Hawley C, Robison L, Reidlinger D, Milanzi E, Bieber B, McCullough K, Johnson DW. Representativeness of the PDOPPS cohort compared to the Australian PD population. Perit Dial Int 2021;:8968608211056242. [PMID: 34758648 DOI: 10.1177/08968608211056242] [Reference Citation Analysis]